Biomedical Engineering

Entrepreneurs from across the Tufts community pitched their innovative ventures at the hybrid competition semi-finals.

Stern Family Professor David Kaplan spoke with CNN about ongoing innovation in cellular agriculture.

Undergraduates in biomedical engineering Patrick Solomon, E24, and Andrew Langley, E23, are working on the threshold of new cancer therapies.

Morphoceuticals Inc, a company co-founded by Stern Family Professor David Kaplan, recently raised $8 million to advance electroceutical approaches to regenerative medicine.

In recognition of National Engineering Week, Tufts students describe myriad inventive opportunities offered by engineering.

Allyson Fournier Caron, E15, and D.J. Hessler Jr., E11, are among a number of Jumbos inducted into the Tufts University Athletics Hall of Fame this year.

PhD student Andrew Stout was featured on NPR Science Friday, telling us how scientists and entrepreneurs are envisioning a future of meat grown from cell culture rather than animals.

Tufts engineers explain how it works and why it holds promise for the future of food.

At inaugural conference, pioneers in the growing industry met to discuss the future of meat made without animals.